Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2603)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2022 (publication date) through Sep 28, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nishimoto A. Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. World J Gastroenterol 2022; 28(28): 3637-3643 [PMID: 36161054 DOI: 10.3748/wjg.v28.i28.3637] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3637.htm |
| Number | Citing Articles |
| 1 |
Tianqi Xu, Alexey Schulga, Elena Konovalova, Sara S. Rinne, Hongchao Zhang, Olga Vorontsova, Anna Orlova, Sergey M. Deyev, Vladimir Tolmachev, Anzhelika Vorobyeva. Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model. International Journal of Molecular Sciences 2023; 24(3): 2838 doi: 10.3390/ijms24032838
|
| 2 |
Priti Gupta, Charles F. Hodgman, Claudia Alvarez-Florez, Keri L. Schadler, Melissa M. Markofski, Daniel P. O’Connor, Emily C. LaVoy. Comparison of three exercise interventions with and without gemcitabine treatment on pancreatic tumor growth in mice: No impact on tumor infiltrating lymphocytes. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1039988
|
| 3 |
Jun-Hao Huang, Wei Guo, Zhe Liu. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World Journal of Gastroenterology 2023; 29(3): 579-581 doi: 10.3748/wjg.v29.i3.579
Abstract(221) |
Core Tip(219) |
Full Article(HTML)(939)
|
Full Article (PDF)-1829K(125)
|
Full Article (Word)-103K(17)
|
Audio-236K(0)
|
Peer-Review Report-325K(16)
|
Answering Reviewers-46K(16)
|
Times Cited (0)
|
Total Visits (2125)
|
Open
|
| 4 |
Junliang Chen, Zhihao Liu, Zhiyuan Wu, Wenjun Li, Xiaodong Tan. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1132424
|